Amylyx Pharmaceuticals (NASDAQ:AMLX) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen lowered shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from a hold rating to a sell rating in a report released on Saturday. A number of other brokerages have also recently commented on AMLX. HC Wainwright raised their price objective on shares of Amylyx Pharmaceuticals from $12.00 to $16.00 and gave the […]
Wall Street Zen lowered shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from a hold rating to a sell rating in a report released on Saturday. A number of other brokerages have also recently commented on AMLX. HC Wainwright raised their price objective on shares of Amylyx Pharmaceuticals from $12.00 to $16.00 and gave the […]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
